Skip To Main Content
Ushma D Upadhyay on Muck Rack

Ushma D Upadhyay

As seen in: MSN, The New York Times, Nature, USA Today, Wiley Online Library, Yahoo News, Aol, Los Angeles Times, PLOS Medicine, The Conversation and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ushma D

Contact Ushma D, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development and Validation of the Agency in Contraceptive Decisions Scale in Uganda and Nigeria

|
By Sneha Challa, Ushma D Upadhyay, Ronald Wasswa, Sylvia Nanono
| Wiley Online Library Verified
BACKGROUND Despite widespread concern that a singular focus on use of modern contraception does not reflect a human rights-based approach to contraception (Senderowicz and Maloney 2022; Dehlendorf et al. 2018; Potter et al. 2019; Speizer, Bremner, and Farid 2022; Holt et al. 2023), global contraceptive programming still prioritizes contraceptive use-focused measures as primary metrics of success.
Open in Who Shared Issue with article?

The FDA’s ‘data guy’ should trust the data on the abortion pill

|
By Ushma D Upadhyay, Kiki Freedman
| The Hill Verified
At a time when abortion access is under attack, Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review will take place or what it will entail, it’s clear that Makary’s decision is part of a strategy to stoke fear and distrust of abortion pills and further prevent patients from making their own decisions about their health.
Open in Who Shared Issue with article?

Opinion - The FDA’s ‘data guy’ should trust the data on the abortion pill

|
By Ushma D Upadhyay, Kiki Freedman
| Aol Verified
At a time when abortion access is under attack, Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review will take place or what it will entail, it’s clear that Makary’s decision is part of a strategy to stoke fear and distrust of abortion pills and further prevent patients from making their own decisions about their health.
Open in Who Shared View Duplicates (2) Issue with article?
See all 149 licensed articles (159 Total)